[HTML][HTML] ISG15 Promotes Progression and Gemcitabine Resistance of Pancreatic Cancer Cells Through ATG7
Y Meng, L Bian, M Zhang, P Zhou, S Zhang… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Chemoresistance is an obstacle of improving pancreatic cancer (PC) prognosis. However,
the biological function of ISG15 in PC and whether it correlates with the resistance to …
the biological function of ISG15 in PC and whether it correlates with the resistance to …
[HTML][HTML] ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair
Y Huo, Z Zong, Q Wang, Z Zhang, H Deng - Oncotarget, 2017 - ncbi.nlm.nih.gov
Tumor cells frequently evolved resistance to cisplatin that greatly compromises the efficacy
of chemotherapy. Identification of the mechanisms underlying drug resistance is important …
of chemotherapy. Identification of the mechanisms underlying drug resistance is important …
ISG15 in cancer: Beyond ubiquitin-like protein
HG Han, HW Moon, YJ Jeon - Cancer letters, 2018 - Elsevier
ISG15, the product of interferon (IFN)-stimulated gene 15, is the first identified ubiquitin-like
protein (Ubl), playing roles not only as an unconjugated form but also as a covalently …
protein (Ubl), playing roles not only as an unconjugated form but also as a covalently …
Inhibition of ISG15 enhances the anti-cancer effect of trametinib in colon cancer cells
S Zhou, M Ren, H Xu, H Xia, Q Tang… - OncoTargets and …, 2019 - Taylor & Francis
Background Colon cancer is one of the most common cancers worldwide. IFN-stimulated
gene 15 (ISG15), a ubiquitin-like molecule, is strongly up-regulated by type I interferon as a …
gene 15 (ISG15), a ubiquitin-like molecule, is strongly up-regulated by type I interferon as a …
ISG15 Inhibits IFN‐α‐Resistant Liver Cancer Cell Growth
X Wan, H Chen, MA Khan, A Xu, F Yang… - BioMed Research …, 2013 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most prevalent tumors worldwide. Interferon‐α
(IFN‐α) has been widely used in the treatment of HCC, but patients eventually develop …
(IFN‐α) has been widely used in the treatment of HCC, but patients eventually develop …
ATG3, a target of miR-431-5p, promotes proliferation and invasion of colon cancer via promoting autophagy
W Huang, C Zeng, S Hu, L Wang… - Cancer management and …, 2019 - Taylor & Francis
Background Studies have indicated that ATG3 could mediate the effects of other tumor-
related regulators in carcinogenesis. However, the expression, role, and mechanism of …
related regulators in carcinogenesis. However, the expression, role, and mechanism of …
[PDF][PDF] ATG4 promotes cell proliferation, migration and invasion in HCC and predicts a poor prognosis.
XJ Zhu, X Jin, L Dai, X Liu, Z Liu - European Review for …, 2020 - europeanreview.org
OBJECTIVE: ATG14, as an autophagy-related protein, has been shown to be implicated in
the progression of tumors by modulating cell autophagy. We aimed at exploring ATG14 level …
the progression of tumors by modulating cell autophagy. We aimed at exploring ATG14 level …
Expressional and mutational analyses of ATG5 gene in prostate cancers
Kim MS, Song SY, Lee JY, Yoo NJ, Lee SH. Expressional and mutational analyses of ATG5
gene in prostate cancers. APMIS 2011; 119: 802–7. Autophagy is an evolutionarily …
gene in prostate cancers. APMIS 2011; 119: 802–7. Autophagy is an evolutionarily …
ATG4B promotes colorectal cancer growth independent of autophagic flux
PF Liu, CM Leung, YH Chang, JS Cheng, JJ Chen… - Autophagy, 2014 - Taylor & Francis
Autophagy is reported to suppress tumor proliferation, whereas deficiency of autophagy is
associated with tumorigenesis. ATG4B is a deubiquitin-like protease that plays dual roles in …
associated with tumorigenesis. ATG4B is a deubiquitin-like protease that plays dual roles in …
Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with …
S Ina, S Hirono, T Noda, H Yamaue - Pancreas, 2010 - journals.lww.com
Objectives: Gemcitabine is the standard chemotherapeutic agent for pancreatic cancer.
Nevertheless, the prognosis of pancreatic cancer patients is still poor. Evaluating the …
Nevertheless, the prognosis of pancreatic cancer patients is still poor. Evaluating the …